Previous Close | 42.26 |
Open | N/A |
Bid | 38.60 |
Ask | 43.00 |
Strike | 100.00 |
Expire Date | 2023-09-15 |
Day's Range | N/A - N/A |
Contract Range | N/A |
Volume | |
Open Interest | 1 |
LAKE FOREST, Calif., March 29, 2023--STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced Warren Foust has been named Chief Operating Officer and Magda Michna, Ph.D., has been named Chief Clinical, Regulatory and Medical Affairs Officer. Both positions will report to STAAR Surgical’s President and CEO, Tom Frinzi.
Staar Surgical (STAA) closed the most recent trading day at $63.48, moving +1.6% from the previous trading session.
Staar Surgical (STAA) closed the most recent trading day at $61.24, moving -1.65% from the previous trading session.